A systematic review of school-based smoking prevention trials with long-term follow-up

Sarah E. Wiehe, Michelle M. Garrison, Dimitri A. Christakis, Beth E. Ebel, Frederick P. Rivara

Research output: Contribution to journalReview article

204 Scopus citations

Abstract

Background: Several systematic reviews of school-based smoking prevention trials have shown short-term decreases in smoking prevalence but have not examined long-term follow-up evaluation. The purpose of this study was to conduct a systematic review of rigorously evaluated interventions for school-based smoking prevention with long-term follow-up data. Methods: We searched online bibliographic databases and reference lists from review articles and selected studies. We included all school-based, randomized, controlled trials of smoking prevention with follow-up evaluation to age 18 or 12th grade and at least 1 year after intervention ended, and that had smoking prevalence as a primary outcome. The primary outcome was current smoking prevalence (defined as at least 1 cigarette in the past month). Results: The abstracts or full-text articles of 177 relevant studies were examined, of which 8 met the selection criteria. The 8 articles included studies differing in intervention intensity, presence of booster sessions, follow-up periods, and attrition rates. Only one study showed decreased smoking prevalence in the intervention group. Conclusions: Few studies have evaluated the long-term impact of school-based smoking prevention programs rigorously. Among the 8 programs that have follow-up data to age 18 or 12th grade, we found little to no evidence of long-term effectiveness.

Original languageEnglish (US)
Pages (from-to)162-169
Number of pages8
JournalJournal of Adolescent Health
Volume36
Issue number3
DOIs
StatePublished - Mar 2005

Keywords

  • School
  • Smoking prevention
  • Youth

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'A systematic review of school-based smoking prevention trials with long-term follow-up'. Together they form a unique fingerprint.

  • Cite this